Privia Health Group (NASDAQ:PRVA) Hits New 1-Year Low at $16.81

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report)'s stock price hit a new 52-week low on Friday . The stock traded as low as $16.81 and last traded at $16.98, with a volume of 89536 shares changing hands. The stock had previously closed at $17.00.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on PRVA shares. Jefferies Financial Group assumed coverage on shares of Privia Health Group in a research note on Monday, February 26th. They issued a "buy" rating and a $25.00 price objective for the company. UBS Group decreased their price target on Privia Health Group from $31.00 to $29.00 and set a "buy" rating on the stock in a report on Friday, March 1st. Evercore ISI dropped their price objective on Privia Health Group from $26.00 to $25.00 and set an "outperform" rating for the company in a research note on Wednesday, February 28th. JPMorgan Chase & Co. decreased their target price on Privia Health Group from $38.00 to $30.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 6th. Finally, Stifel Nicolaus dropped their price target on Privia Health Group from $28.00 to $24.00 and set a "buy" rating for the company in a research note on Wednesday, May 1st. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $25.33.

Privia Health Group Trading Down 0.6 %

The business's 50 day simple moving average is $18.87 and its 200 day simple moving average is $20.82. The firm has a market capitalization of $2.02 billion, a PE ratio of 112.67, a PEG ratio of 2.31 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.02). Privia Health Group had a return on equity of 3.13% and a net margin of 1.11%. The company had revenue of $440.80 million during the quarter, compared to analysts' expectations of $425.81 million. During the same quarter in the prior year, the business posted $0.14 EPS. The company's revenue was up 21.0% on a year-over-year basis. Analysts forecast that Privia Health Group, Inc. will post 0.24 earnings per share for the current year.

Insider Activity at Privia Health Group

In other Privia Health Group news, EVP Thomas Bartrum sold 2,252 shares of Privia Health Group stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total transaction of $41,481.84. Following the completion of the transaction, the executive vice president now directly owns 103,862 shares of the company's stock, valued at $1,913,138.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Privia Health Group news, EVP Thomas Bartrum sold 2,252 shares of the firm's stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total value of $41,481.84. Following the completion of the sale, the executive vice president now owns 103,862 shares of the company's stock, valued at $1,913,138.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Parth Mehrotra sold 12,219 shares of the company's stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total value of $225,073.98. Following the transaction, the chief executive officer now directly owns 261,640 shares in the company, valued at approximately $4,819,408.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 49,390 shares of company stock worth $897,700. Company insiders own 14.20% of the company's stock.

Institutional Trading of Privia Health Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of Privia Health Group during the fourth quarter valued at $27,959,000. First Light Asset Management LLC purchased a new stake in Privia Health Group in the 1st quarter valued at about $21,620,000. Riverbridge Partners LLC grew its stake in Privia Health Group by 17.5% in the 1st quarter. Riverbridge Partners LLC now owns 5,399,662 shares of the company's stock worth $105,779,000 after acquiring an additional 804,304 shares in the last quarter. Avidity Partners Management LP increased its position in shares of Privia Health Group by 43.1% during the third quarter. Avidity Partners Management LP now owns 1,545,100 shares of the company's stock worth $35,537,000 after acquiring an additional 465,294 shares during the period. Finally, Northern Trust Corp increased its position in shares of Privia Health Group by 28.7% during the third quarter. Northern Trust Corp now owns 1,344,327 shares of the company's stock worth $30,920,000 after acquiring an additional 299,395 shares during the period. Hedge funds and other institutional investors own 94.48% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.